These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16870748)

  • 1. Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11.
    Okuda D; Yomogida S; Tamura H; Nagaoka I
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2602-7. PubMed ID: 16870748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Heumann D
    J Immunol; 2001 Sep; 167(6):3329-38. PubMed ID: 11544322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of the antimicrobial activities of guinea pig cathelicidin CAP11-derived peptides by amino acid substitutions.
    Okuda D; Yomogida S; Kuwahara-Arai K; Hitamatsu K; Tamura H; Nagaoka I
    Int J Mol Med; 2009 Apr; 23(4):501-8. PubMed ID: 19288026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic actions of antibacterial neutrophil defensins and cathelicidins.
    Nagaoka I; Hirota S; Yomogida S; Ohwada A; Hirata M
    Inflamm Res; 2000 Feb; 49(2):73-9. PubMed ID: 10738945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation.
    Nagaoka I; Tsutsumi-Ishii Y; Yomogida S; Yamashita T
    J Biol Chem; 1997 Sep; 272(36):22742-50. PubMed ID: 9278433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies on the extracellular release and biological activity of guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and defensins.
    Yomogida S; Nagaoka I; Yamashita T
    Comp Biochem Physiol B Biochem Mol Biol; 1997 Jan; 116(1):99-107. PubMed ID: 9080667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial cathelicidin peptide CAP11 inhibits the lipopolysaccharide (LPS)-induced suppression of neutrophil apoptosis by blocking the binding of LPS to target cells.
    Nagaoka I; Yomogida S; Tamura H; Hirata M
    Inflamm Res; 2004 Nov; 53(11):609-22. PubMed ID: 15693610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial cathelicidin peptide CAP11 suppresses the anandamide production from lipopolysaccharide-stimulated mononuclear phagocytes.
    Murakami T; Yomogida S; Someya A; Kuwahara-Arai K; Tamura H; Nagaoka I
    FEBS Lett; 2007 Jan; 581(1):140-4. PubMed ID: 17184778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial cathelicidin peptide CAP11 suppresses HMGB1 release from lipopolysaccharide-stimulated mononuclear phagocytes via the prevention of necrotic cell death.
    Shibusawa K; Murakami T; Yomogida S; Tamura H; Nagaoka I
    Int J Mol Med; 2009 Mar; 23(3):341-6. PubMed ID: 19212652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial cathelicidin polypeptide CAP11 suppresses the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice.
    Murakami T; Obata T; Kuwahara-Arai K; Tamura H; Hiramatsu K; Nagaoka I
    Int Immunol; 2009 Aug; 21(8):905-12. PubMed ID: 19556302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
    Nan YH; Bang JK; Jacob B; Park IS; Shin SY
    Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
    Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
    Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
    Datta A; Kundu P; Bhunia A
    J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.
    Madanchi H; Ebrahimi Kiasari R; Seyed Mousavi SJ; Johari B; Shabani AA; Sardari S
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1582-1593. PubMed ID: 32445120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence on size and shape of non-nature amino acids in the enhancement of lipopolysaccharide (LPS) neutralizing activities of antimicrobial peptides.
    Chih YH; Wang SY; Yip BS; Cheng KT; Hsu SY; Wu CL; Yu HY; Cheng JW
    J Colloid Interface Sci; 2019 Jan; 533():492-502. PubMed ID: 30176540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
    Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application.
    Nell MJ; Tjabringa GS; Wafelman AR; Verrijk R; Hiemstra PS; Drijfhout JW; Grote JJ
    Peptides; 2006 Apr; 27(4):649-60. PubMed ID: 16274847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity and bacterial-membrane interaction of ovine-derived cathelicidins.
    Anderson RC; Hancock RE; Yu PL
    Antimicrob Agents Chemother; 2004 Feb; 48(2):673-6. PubMed ID: 14742236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
    Lee JK; Seo CH; Luchian T; Park Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.